Biopoint Annual Software License Support Renewal
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Office of Information and Technology (OIT), IT Operations and Services (ITOPS) has a requirement for annual software license support for the BioPoint Patient Identification Wristband System. This is a Firm-Fixed-Price delivery order issued under the NASA SEWP V GWAC. The total estimated value, including options, is $568,464.17. This action is an Award Notice for a brand-name requirement.
Purpose & Scope
This requirement is for annual software license support for the Advarra's BioPoint Patient Identification (ID) Wristband System, currently utilized in six VA facilities within VISN 21. The support includes application version upgrades with new features, enhanced functionality (requiring VPN access), upgrade installation documentation, and telephone support. No hardware or new software will be procured; the action is solely for annual software support. The BioPoint system is critical for patient identification, security, and care, using features like color photographs and barcodes for verification.
Contract Details
- Contract Type: Firm-Fixed-Price (FFP) delivery order
- Contract Vehicle: NASA Solutions for Enterprise-Wide Procurement (SEWP) V Governmentwide Acquisition Contract (GWAC)
- Period of Performance: A base period of 12 months with four (4) 12-month option periods.
- Total Estimated Value: $568,464.17 (inclusive of all option periods).
- Award Date: Published on April 29, 2026.
Eligibility & Justification
This action is justified as an exception to fair opportunity due to a brand name requirement, citing FAR 16.505(a)(4) and 41 U.S.C. 4106(c)(2). The justification is based on the unique and highly specialized nature of the BioPoint system, which only the Original Equipment Manufacturer (OEM) or its authorized resellers can provide. Market research confirmed that alternative systems do not offer the same range of functionalities, particularly the visual patient verification feature. Transitioning to a new system is estimated to cost approximately $3,000,000.00 for the six HCS and would not be recouped through competition.
Additional Notes
The government will continue market research for future actions related to patient identification systems. The justification for this exception will be made publicly available within 14 days of the award. Primary contact is Shakiya Harris (shakiya.harris@va.gov, 512-981-4021).